Send me a link:

*Text messaging rates may apply.

 Dow Up 0.36% Nasdaq Up 0.71%

Soligenix, Inc. (SNGX)

-OTC BB
2.14 0.06(2.73%) Jul 22, 2:44PM EDT
Prev Close:2.20
Open:2.20
Bid:N/A
Ask:N/A
1y Target Est:4.00
Beta:3.8
Next Earnings Date:N/A
Day's Range:2.09 - 2.20
52wk Range:1.40 - 2.50
Volume:9,389
Avg Vol (3m):26,881
Market Cap:42.74M
P/E (ttm):N/A
EPS (ttm):-0.70
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for SNGX

Comparison

Symbol% ChgMkt Cap
SNGXDown 2.73%42.74M
AVNR843.90M
CLDX1.14B
SNY136.88B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):13.58
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.46
Quarterly EPS Est (Jun-14) :-0.07
Mean Recommendation*:1.5
PEG Ratio (5 yr expected):-4.74

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Soligenix, Inc., a clinical stage biopharmaceutical company, is engaged in developing products to treat life-threatening side effects of cancer treatments and serious gastrointestinal diseases, and various biodefense vaccines and therapeutics. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback